Categories
Organizations

Memorial Sloan Kettering Earns Top Cancer Hospital Prize with the Help of Vital Philanthropy

Memorial Sloan-Kettering Cancer Center
Memorial Sloan Kettering Cancer Center IMG: via Stanford.

News recently broke that for the first time in seven years, MD Anderson Cancer Center was bumped to the runner-up spot in the U.S. News & World Report rankings of the best hospitals. According to The Clinical Cancer Letter, “MD Anderson Cancer Center’s uninterrupted seven-year stretch as the top cancer hospital in the U.S. News & World Report rankings has come to an end. Memorial Sloan Kettering Cancer Center has broken the spell of being the perpetual runner-up and moved to the lead.”

Memorial Sloan Kettering’s new title as best cancer center in the United States is somewhat unsurprising, given the recent oncological developments and innovations that have been made there. The cancer center has been regarded as one of the world’s premier medical institutions, and has garnered significant amounts of funding from donors who believe in its work and tireless mission to fight and treat cancer. Many major developments to the hospital’s facilities could not have been made without the generous donations of philanthropists.

Earlier this year, the Marie-Josée and Henry R. Kravis Foundation donated an astounding gift of $100 million to the cancer center, which allowed for the formation of a division that utilizes advanced, cutting-edge technology. The Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) has allowed for groundbreaking advancements in cancer research and patient care. According to Inside Philanthropy, the $100 million gift is the largest donation the Kravis Foundation has made.

Earning the title of best cancer hospital is a true achievement for Memorial Sloan Kettering, and validates the important, tireless work it does. According to Memorial Sloan Kettering, the “CMO brings together researches with many different areas of expertise – including cancer biology, pathology, bioinformatics, and systems biology – to undertake a vast, translational research program,” of the broadened reach the Cancer Center has because of the new endeavors of the CMO.

Learn more about how Memorial Sloan Kettering Cancer Center earned the title of best hospital by visiting the U.S. News and World Report Hospital Rankings.

Categories
Organizations Resources

Groundbreaking Advancements in Medicine Made Possible By Donor Generosity at Memorial Sloan Kettering

Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center IMG: via Stanford.

Memorial Sloan Kettering Cancer Center is one of the world’s premier institutions tirelessly devoted to curing and treating cancer, as well as developing new technologies to help prevent the deadly disease. As the world’s largest and oldest private cancer center, Memorial Sloan Kettering has dedicated more than 130 years to exceptional patient care and groundbreaking research and cancer treatment developments. The prestigious cancer center would not be as globally renowned as it is today, however, without significant contributions from philanthropists and generous, committed donors.

Two of those donors are Henry R. Kravis and his wife Marie-Josée Kravis, prominent philanthropists who have invested a great amount of time and vital funding in supporting Memorial Sloan Kettering’s work.

Recently, the Marie-Josée and Henry R. Kravis Foundation donated a gift of $100 million to the cancer center, which allowed for the formation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) to be formed. This division of the cancer center was designed to transform and innovate cancer care using cutting edge research and technology, and would not have been made possible without the remarkable generosity of the Kravises.

Advancements in medicine at Memorial Sloan Kettering include a new procedure called the “tumor sequencing test,” which was designed to provide more personalized treatment options to patients.

According to Dr. Eva Kiesler, “A new genome-sequencing test developed at Memorial Sloan Kettering allows our doctors to quickly find out whether a patient’s tumor carries clinically useful mutations – including aberrations that make cancers vulnerable to particular drugs – and to match individual patients with available therapies or clinical trials that will most benefit them,” of the advancements in medicine being made at the center.

The primary goal of the CMO “is to expedite and streamline cancer genomics research to guide cancer treatment,” which will ultimately provide better treatment options for every single person who seeks care at Memorial Sloan Kettering.

Learn more about the new oncology center and the donation that made it possible by visiting www.mskcc.org.